+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Tumor Necrosis Factor Inhibitor Drugs Market Report 2025 - Product Thumbnail Image

Tumor Necrosis Factor Inhibitor Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Chemotherapy Market Report 2025 - Product Thumbnail Image

Chemotherapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Cancer Immunotherapy Market Report 2025 - Product Thumbnail Image

Cancer Immunotherapy Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Tumor Infiltrating Lymphocytes Market Report 2025 - Product Thumbnail Image

Tumor Infiltrating Lymphocytes Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Recombinant Proteins Market 2024-2028 - Product Thumbnail Image

Recombinant Proteins Market 2024-2028

  • Report
  • July 2024
  • 178 Pages
  • Global
From
Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • September 2024
  • 247 Pages
  • Global
From
From
From
Placenta Growth Factor Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Placenta Growth Factor Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator